We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology

News   Jul 24, 2012

 
Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology
 
 
 

RELATED ARTICLES

Gene Therapy for Duchenne Muscular Dystrophy Successful in Pigs

News

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

READ MORE

Compound Awakens Cancer Cells’ Self-destruct System

News

Researchers develop a compound that, in mice, awakened cancer cells’ "self-destruct" process, killing the cancer cells and consequently stopping their spread, while leaving "normal" cells untouched.

READ MORE

Gene Therapy for Life-limiting Blood Disorder Becomes Commercially Available

News

bluebird bio Inc. have announced that their gene therapy for the blood disorder transfusion-dependent β-thalassemia (TDT) is commercially available for the first time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE